ParaPRO
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, ParaPRO sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).
ParaPRO: 11 sponsored US clinical trials, none currently recruiting.
ParaPRO sponsors 11 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 11 completed. 5 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pediculosis Capitis, with 1 trials.
Top-decile sponsor footprint
ParaPRO ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
11 of 11 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
11 total, page 1 of 1
Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
NCT02485704
Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
NCT02485717
Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation
NCT01660321
NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers
NCT00605956
Phototoxicity Potential of NatrOVA Creme Rinse - 1%
NCT00591331
Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice
NCT00545168
Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice
NCT00545753
A Safety and Efficacy Pilot Study Comparing NatrOVA Creme Rinse 1% and NIX Creme Rinse
NCT00857935
A Pharmacokinetic (PK) Study of NatrOVA Topical Creme (1%) in Pediatric Subjects 6 to 24 Months of Age
NCT00410709
A Dose Ranging Study of Different Strengths of Spinosad Topical Creme in Subjects With Pediculosis Capitis
NCT00311779
A Pilot Dose Ranging Study of Spinosad Creme Rinse
NCT00858481
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 3 |
| Phase 3 | 4 |
| Phase 4 | 1 |
Therapeutic Areas
How the ParaPRO archive is shaped
11 indexed studies, none listed as recruiting (0% open); 11 completed (100%).
Phase mix: 5 late (III/IV) vs 6 early (I/II) (balanced across stages).
Top condition: Pediculosis Capitis (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
ParaPRO: archived-pipeline peers nationwide
Peers matched on 11 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
ParaPRO sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 11 archived trials
- Aderans Research Institute · 11 trials · 0% recruiting
- Aegerion Pharmaceuticals · 11 trials · 0% recruiting
- Allena Pharmaceuticals · 11 trials · 0% recruiting
- AOBiome · 11 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this ParaPRO page
11 registered trials is a research-attention snapshot, not an endorsement of ParaPRO or any single study.
- None of ParaPRO's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Pediculosis Capitis is the condition ParaPRO studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pediculosis Capitis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
ParaPRO pipeline card: 11 registered trials from official public datasets.Report a data error.